Methamphetamine Abuse
57
5
8
36
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
14 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
3 terminated out of 57 trials
92.3%
+5.7% vs benchmark
2%
1 trials in Phase 3/4
39%
14 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 36 completed trials
Clinical Trials (57)
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
rTMS for Craving in Methamphetamine Use Disorder
Ketamine for Methamphetamine Use Disorder
Contingency Management for Drug Use: Does Age Matter?
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Mood and Decision-making in Methamphetamine Use Disorder
Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
Methamphetamine, PrEP, and Intersectional Stigma Study
Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
The Getting Off App for Methamphetamine-Using Gay and Bisexual Men
Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)
tACS Treatment for Cognitive Impairments in Methamphetamine Addicts
A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants
rTMS for Stimulant Use Disorders
Cardiovascular Effects of Prenatal Methamphetamine Exposure
Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200